Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study
Abstract
OBJECTIVE: The influence of postprandial blood glucose on diabetes complications is intensively debated. We aimed to evaluate the predictive role of both fasting and postprandial blood glucose on cardiovascular events in type 2 diabetes and the influence of gender. METHODS: In a population of 529 (284 men and 245 women) consecutive type 2 diabetic patients attending our diabetes clinic, we evaluated the relationships, corrected for cardiovascular risk factors and type of treatment, between cardiovascular events in a 5-yr follow-up and baseline values of hemoglobin A1c (HbA1c) and blood glucose measured: 1) after an overnight fast, 2) after breakfast, 3) after lunch, and 4) before dinner. Continuous variables were categorized into tertiles. RESULTS: We recorded cardiovascular events in 77 subjects: 54 of 284 men (19%) and 23 of 245 women (9.4%). Univariate analysis indicated that cardiovascular events were associated with increasing age, longer diabetes duration, and higher HbA1c and fibrinogen in men, and higher systolic blood pressure, albumin excretion rate, HbA1c, and all blood glucose values in women. Smoking was more frequent in subjects with events. When all blood glucose values and HbA1c were introduced simultaneously in the models, only blood glucose after lunch predicted cardiovascular events, with hazard ratio of the third tertile vs. the first and the second tertiles greater in women (5.54; confidence interval, 1.45-21.20) than in men (2.12; confidence interval, 1.04-4.32; P < 0.01). CONCLUSIONS: Postprandial, but not fasting, blood glucose is an independent risk factor for cardiovascular events in type 2 diabetes, with a stronger predictive power in women than in men, suggesting that more attention should be paid to postprandial hyperglycemia, particularly in women.
AI snapshot
Written from the paper’s full text.
TL;DR
In a 5-year follow-up of 529 type 2 diabetes patients, blood glucose measured after lunch independently predicted cardiovascular events, whereas fasting glucose did not. The predictive effect was stronger in women than in men.
Key findings
- Cardiovascular events occurred in 77 participants: 54 of 284 men (19%) and 23 of 245 women (9.4%).
- When all glucose measurements and HbA1c were included together, only post-lunch blood glucose remained a significant predictor of cardiovascular events.
- The hazard ratio for the third tertile versus the first and second tertiles of post-lunch glucose was 5.54 (95% CI, 1.45–21.20) in women and 2.12 (95% CI, 1.04–4.32) in men; the gender difference was statistically significant (P < 0.01).
- HbA1c correlated with all measured glucose values in both genders, but fasting glucose had low predictive value for events.
Methods
- Prospective cohort study of 529 consecutive type 2 diabetes patients at an Italian diabetes clinic, enrolled in 1995 and followed through 2000.
- Baseline assessment included cardiovascular risk factors, HbA1c, and glucose profiles: fasting, 2 hours after breakfast, 2 hours after lunch, and before dinner.
- Cox proportional hazards models were fitted separately by gender, with glucose and HbA1c values categorized into tertiles and adjusted for age, diabetes duration, previous cardiovascular events, systolic blood pressure, albumin excretion rate, fibrinogen, smoking, and type of treatment.
Limitations
- The paper states that a possible limitation is the limited number of cardiovascular events in women.
- The text makes evident that glucose before lunch was unavailable for most patients, so lunch-induced glucose excursions could not be evaluated across the whole cohort.
- Glucose profiles were measured either in hospital by nurses or at home by patients using a reflectance meter, which may introduce measurement variability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 45 cited sources checked · 0 supported · 0 flagged
- Findingown data§ Results
In men, among the single blood glucose measures, only post-lunch blood glucose was linked to a significantly higher risk of a first cardiovascular event when the third tertile was compared with the first and second tertiles, after adjustment for cardiovascular risk factors and treatment.
“In men, when models were fitted with single BG values (models A-D) and the third tertile was compared with the first and the second tertiles, a significantly increased risk of cardiovascular events was observed only for BGAL.”
Quote in the paperNot a substantial claim - Findingreasoning§ Discussion
In the present study, blood glucose after breakfast did not predict cardiovascular events.
“BG after breakfast predicted cardiovascular events in the DIS, but not in our study”
Quote in the paperNot a substantial claim - Findingown data§ First Published Online December 13, 2005
When all blood glucose values and HbA1c were entered together, only post-lunch glucose predicted cardiovascular events.
“When all blood glucose values and HbA1c were introduced simultaneously in the models, only blood glucose after lunch predicted cardiovascular events”
Quote in the paperSubstantial claim- Rests on an assumption: The blood glucose profiles used at baseline reflect the patients' usual glycemic control.
- Findingown data§ Results
In women, when all blood glucose values were considered together, only the hazard ratio for post-lunch blood glucose remained statistically significant, both without and with HbA1c in the models.
“When all BG values were considered together, only HR for BGAL remained statistically significant both without and with the addition of HbA1c in the models (model E and J).”
Quote in the paperSubstantial claim - Findingown data§ Results
Men with and without cardiovascular events differed in age, diabetes duration, previous cardiovascular events, fibrinogen, and HbA1c.
“Men without and with cardiovascular events differed for age, known diabetes duration, previous cardiovascular events, fibrinogen, and HbA1c”
Quote in the paperNot a substantial claim
- Findingown data§ Results
In men, when all blood glucose values and HbA1c were included together, being in the third tertile of post-lunch blood glucose carried about twice the risk of cardiovascular events compared with the other tertiles (model J).
“Moreover, when all BG values were added together and with HbA1c, the risk for men in the third tertile of BGAL was twice that for subjects in the other tertiles (model J).”
Quote in the paperNot a substantial claim - Findingown data§ Results
Hypoglycemic treatment had no significant effect on cardiovascular events when men and women were analyzed separately or together.
“The effect of hypoglycemic treatment was not significant when men and women were considered separately or pooled together.”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
HbA1c values were higher in men and women who developed cardiovascular events.
“Actually, HbA1c values, incorporating information derived from both preand postprandial BG, were higher in men and women developing events.”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
Cardiovascular events were much more frequent in men than in women in the present study.
“In our study, cardiovascular events were much more frequent in men”
Quote in the paperSubstantial claim - Findingown data§ Discussion
In patients who developed cardiovascular events, the differences between blood glucose after lunch and after breakfast were greater than in patients who did not develop events.
“Furthermore, in patients developing cardiovascular events, the differences between BG values after lunch and after breakfast (which underestimate the after lunch glycemic increases) are greater than those in patients not developing events”
Quote in the paperSubstantial claim - Findingown data§ Discussion
Baseline features show that differences in blood glucose control at various time points are much greater in women than in men.
“The simple observation of baseline features in subjects developing or not developing cardiovascular events at the follow-up shows that differences in BG control at the various time points are much greater in women.”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
Other well-known cardiovascular risk factors did not differ significantly between patients who developed events and those who did not.
“This is even more relevant when we consider that other well-known cardiovascular risk factors were not significantly different in the two groups.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Discussion
The gender-related difference in the predictive effect of postprandial blood glucose is described here for the first time, because earlier studies on gender used postchallenge rather than postprandial blood glucose and were mostly conducted in the general population.
“As far as we know, this is the first time that this gender-related difference has been described, because previous studies concerning gender took into account postchallenge, not postprandial, BG, and the large majority of them were carried out in the general population, as discussed in the introduction.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
When blood glucose values at all times and HbA1c are entered simultaneously, postprandial but not fasting blood glucose is an independent risk factor for cardiovascular events in type 2 diabetic patients.
“Furthermore, our study confirms that when BG values at all times and HbA1c are introduced in the models simultaneously, postprandial, but not fasting, BG is an independent risk factor for cardiovascular events in type 2 diabetic patients, as previously observed in the DIS (11).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] 11. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J 1996 Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577-1583
Not checked in the free run.
- Premisecitation§ First Published Online December 13, 2005
Hyperglycemia appears to have a stronger effect on cardiovascular death in women than in men.
“In contrast, hyperglycemia seems to influence cardiovascular mortality more strongly in women than in men.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [4] 4. symptomatic hyperglycaemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516 4. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL 1991 Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265:627-631
Not checked in the free run.
- cites [20] 20. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P 1999 Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14786 middle-aged men and women in Finland. Circulation 99:1165-1172
Not checked in the free run.
- cites [3] 3. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J 1986 Relationships of clinical diabetes and
Not checked in the free run.
- Premisecitation§ First Published Online December 13, 2005
Many studies report that diabetes and asymptomatic hyperglycemia give women a larger relative cardiovascular risk than men.
“many studies show that both diabetes (4, 20) and asymptomatic hyperglycemia (3, 5, 7, 21) confer a greater relative risk of cardiovascular disease to women than to men”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [4] 4. symptomatic hyperglycaemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516 4. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL 1991 Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265:627-631
Not checked in the free run.
- cites [20] 20. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P 1999 Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14786 middle-aged men and women in Finland. Circulation 99:1165-1172
Not checked in the free run.
- cites [3] 3. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J 1986 Relationships of clinical diabetes and
Not checked in the free run.
- Interpretationreasoning§ Discussion
Because hypoglycemic drugs are usually taken in the morning, blood glucose after breakfast is even lower than fasting blood glucose.
“For this reason and because hypoglycemic drugs are usually given in the morning, BG after breakfast is even lower than FBG.”
Quote in the paperSubstantial claim- Rests on an assumption: Hypoglycemic drugs are usually given in the morning.
- Premisecitation§ First Published Online December 13, 2005
The DECODE Study Group found adjusted hazard ratios for cardiovascular death of 1.40 in men and 3.29 in women among subjects meeting diabetes criteria.
“the DECODE Study Group, by analyzing both fasting and postchallenge glucose concentrations from 14 prospective European cohorts, found that the multivariate adjusted hazard ratios for cardiovascular mortality in subjects who met the criteria for diabetes were 1.40 in men and 3.29 in women (25).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] 25. DECODE Study Group 2003 Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46:608-617
Not checked in the free run.
- Interpretationown data§ First Published Online December 13, 2005
Postprandial glucose predicts cardiovascular events more strongly in women than in men with type 2 diabetes.
“with a stronger predictive power in women than in men”
Quote in the paperSubstantial claim- Rests on an assumption: The blood glucose profiles used at baseline reflect the patients' usual glycemic control.
- Premisecitation§ Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study
In epidemiological research, blood glucose levels in the upper normal range independently predict cardiovascular disease.
“Epidemiological studies demonstrate that blood glucose (BG) concentrations in the upper normal range are an independent risk factor for cardiovascular disease (3-8), as discussed in a meta-regression analysis (9)”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [3] 3. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J 1986 Relationships of clinical diabetes and
Not checked in the free run.
- cites [4] 4. symptomatic hyperglycaemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516 4. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL 1991 Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265:627-631
Not checked in the free run.
- cites [5] 5. Wilson PWF, Cupples LA, Kannel WB 1991 Is hyperglycaemia associated with cardiovascular disease? The Framingham Study. Am Heart J 121:586-590
Not checked in the free run.
- cites [6] 6. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM, HeineRJ 1999 Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study. Diabetologia 42:926-931
Not checked in the free run.
- cites [7] 7. DECODEStudy Group 2001 Glucose tolerance and cardiovascular mortality: comparison of the fasting and the 2-hour diagnostic criteria. Arch Intern Med 161:397-404
Not checked in the free run.
- cites [8] 8. Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL 2001 Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 24:1397-1402
Not checked in the free run.
- cites [9] 9. Coutinho M, Gerstein H, Poque J, Wang Y, Yusuf S 1999 The relationship between glucose and incident cardiovascular events: a meta regression analysis of published data from 20 studies of 95.783 individuals followed for 12.4 years. Diabetes Care 22:233-240
Not checked in the free run.
- Study design and conductown data§ Discussion
A possible limitation of the study is the limited number of cardiovascular events in women.
“A possible limitation of our study is the presence of a limited number of cardiovascular events in women.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
The present study indicates that postprandial blood glucose control is relevant for preventing cardiovascular events in type 2 diabetic patients.
“Our study indicates the relevance of postprandial blood glucose control in the prevention of cardiovascular events in type 2 diabetic patients.”
Quote in the paperSubstantial claim - Premisecitation§ Discussion
Correction of postprandial blood glucose is more effective than correction of fasting blood glucose on regression of carotid intima media thickness and decrease in circulating inflammatory markers in type 2 diabetic patients.
“Furthermore, correction of postprandial BG is more effective than correction of fasting BG on the regression of carotid intima media thickness and the decrease in circulating inflammatory markers in type 2 diabetic patients (37).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] 37. Esposito K, Giugliano D, Nappo F, Marfella R for the Campanian Postprandial Hyperglycemia Study Group 2004 Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110:214-219
Not checked in the free run.
- Premisecitation§ Discussion
In the STOP-NIDDM trial, treating impaired glucose tolerance patients with acarbose for an average of 3.3 years to reduce postprandial hyperglycemia produced a 49% relative risk reduction of major cardiovascular events.
“the STOP-NIDDM trial, in which patients affected by impaired glucose tolerance were treated with acarbose for an average of 3.3 yr to reduce postprandial hyperglycemia, showed a 49% relative risk reduction of major cardiovascular events (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] 34. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOPNIDDM Trial Research Group 2003 Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486-494
Not checked in the free run.
- Interpretationreasoning§ Discussion
The present study could support the predictive role of glucose spikes.
“In this light, our study could support the predictive role of so-called glucose spikes (32-34).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [32] 32. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, de Marco R 1997 Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation 96:1750-1754
Not checked in the free run.
- cites [33] 33. Temelkova-Kurktschiev T, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M 2000 Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 23:1830-1834
Not checked in the free run.
- cites [34] 34. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOPNIDDM Trial Research Group 2003 Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486-494
Not checked in the free run.
- Interpretationreasoning§ Discussion
The differences between post-lunch and post-breakfast blood glucose could be even larger in the present patients because many were taking hypoglycemic drugs usually administered before breakfast.
“The differences could be even greater in the patients investigated in the present study, because many of them were taking hypoglycemic drugs usually administered before breakfast.”
Quote in the paperNot a substantial claim- Rests on an assumption: Hypoglycemic drugs are usually given in the morning.
- Interpretationreasoning§ Discussion
The greater post-lunch versus post-breakfast blood glucose differences in patients who developed cardiovascular events suggest that higher lunch-induced blood glucose excursions occurred.
“a fact suggesting the occurrence of higher lunch-induced BG excursions.”
Quote in the paperSubstantial claim- Rests on an assumption: The differences between blood glucose after lunch and after breakfast underestimate the after-lunch glycemic increases.
- Interpretationown data§ Discussion
The present study shows that blood glucose influences the occurrence of cardiovascular events much more strongly in women than in men after correction for cardiovascular risk factors and type of therapy and when all daily blood glucose values and HbA1c are considered in the models.
“Furthermore, our study shows that BG influences the occurrence of cardiovascular events much more strongly in women than in men after correction for cardiovascular risk factors and type of therapy and when all daily BG values and HbA1c are considered in the models.”
Quote in the paperSubstantial claim
- May combine two claims. 19
- Classified as probably not a substantial claim. 27
May combine two claims.
Findingown data§ ResultsIn women, when each blood glucose value was considered separately, hazard ratios for fasting blood glucose, post-lunch blood glucose, and post-dinner blood glucose were significant; these results held when HbA1c was included.
“In women, when each BG value was considered independently of the others (models A-D), HR for FBG, BGAL, and BGBD were significant; the results were confirmed when HbA1c was included in the models (models F-I).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ ResultsHbA1c correlated with all blood glucose values in both men and women.
“HbA1c was correlated ( P < 0.0001) with all BG values in both men and women.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ ResultsIn pooled multiple regression, all glucose values remained significantly correlated with HbA1c (FBG r=0.104, P<0.046; BGAB r=0.216, P<0.0001; BGAL r=0.229, P<0.0001; BGBD r=0.097, P=0.049).
“When HbA1c and BG values from both genders were pooled together, multiple regression analysis showed that all values remained significantly correlated with HbA1c (r = 0.104, P < 0.046 for FBG; r = 0.216, P < 0.0001 for BGAB; r = 0.229, P < 0.0001 for BGAL; and r = 0.097, P = 0.049 for BGBD).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ ResultsWomen with and without cardiovascular events differed in previous cardiovascular events, systolic blood pressure, AER, HbA1c, and all blood glucose values.
“women differed for previous cardiovascular events, systolic blood pressure, AER, HbA1c, and all BG”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ ResultsAt baseline, men and women differed significantly in age, diabetes duration, previous cardiovascular events, smoking, hypoglycemic therapy, BMI, total/HDL cholesterol ratio, fibrinogen, AER, and HbA1c.
“Men and women differed significantly for age, diabetes duration, previous cardiovascular events, smoking habit, hypoglycemic therapy, BMI, total/HDL cholesterol ratio, fibrinogen, AER, and HbA1c.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown data§ ResultsAmong the 77 cardiovascular events, 38 (49.3%) were coronary, 26 (33.8%) cerebrovascular, and 13 (16.9%) peripheral vascular.
“38 of 77 (49.3%) were coronary (29 in men and nine in women), 26 of 77 (33.8%) were cerebrovascular (14 in men and 12 in women), and 13 of 77 (16.9%) were peripheral vascular (11 in men and two in women).”
Quote in the paperNot a substantial claim- Rests on an assumption: Record linkage with hospital discharge and population registers accurately identifies cardiovascular events and deaths.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown data§ ResultsTwenty-three participants died: five from cardiovascular causes, 10 from cancer, and eight from other causes; two deaths from cancer or other causes were preceded by a cardiovascular event.
“Twenty-three participants died: five from cardiovascular events, 10 from neoplasia, and eight from other reasons; death was preceded by a cardiovascular event in two subjects who died from neoplasia or other causes.”
Quote in the paperNot a substantial claim- Rests on an assumption: Record linkage with hospital discharge and population registers accurately identifies cardiovascular events and deaths.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ ResultsCardiovascular events occurred in 77 patients: 54 of 284 men (19%) and 23 of 245 women (9.4%).
“We recorded cardiovascular events in 77 patients, 54 in 284 men (19%) and 23 in 245 women (9.4%)”
Quote in the paperNot a substantial claim- Rests on an assumption: Record linkage with hospital discharge and population registers accurately identifies cardiovascular events and deaths.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ ResultsWhen men and women were pooled, smoking habit was significantly associated with cardiovascular events (χ2=7.8; P=0.02).
“When both men and women were pooled together, the effect of smoking habit was significant ( 𝛘 2 = 7.8; P = 0.02).”
- Also stated in: § First Published Online December 13, 2005 · plain
“Smoking was more frequent in subjects with events.”
Quote in the paperNot a substantial claim- Also stated in: § First Published Online December 13, 2005 · plain
May combine two claims.
Findingown data§ ResultsBlood glucose after lunch was higher than after breakfast (P=0.02 in men, P=0.007 in women), with larger differences in patients who had events.
“BGAL was higher than BGAB ( P = 0.02 in men and P = 0.007 in women; Table 1), with greater differences in patients with events (Table 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ ResultsCorrelation coefficients between HbA1c and fasting, post-breakfast, post-lunch, and pre-dinner glucose were 0.388, 0.425, 0.483, and 0.390 in men and 0.452, 0.512, 0.458, and 0.421 in women.
“linear correlation coefficients between HbA1c and FBG, BGAB, BGAL, and BGBD were, respectively, in men, r = 0.388, r = 0.425, r = 0.483, and r = 0.390; and in women, r = 0.452, r = 0.512, r = 0.458, and r = 0.421.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ First Published Online December 13, 2005The hazard ratio for the top tertile versus the lower two tertiles of post-lunch glucose was 5.54 (CI 1.45-21.20) in women and 2.12 (CI 1.04-4.32) in men, with a significant sex difference (P<0.01).
“with hazard ratio of the third tertile vs. the first and the second tertiles greater in women (5.54; confidence interval, 1.45-21.20) than in men (2.12; confidence interval, 1.04-4.32; P < 0.01).”
Quote in the paperSubstantial claim- Rests on an assumption: The blood glucose profiles used at baseline reflect the patients' usual glycemic control.
May combine two claims.
Findingown data§ ResultsIn model J, the hazard ratio for post-lunch blood glucose was higher in women (5.54; 95% CI 1.45-21.20) than in men (2.12; 95% CI 1.04-4.32), and the difference between genders was statistically significant (P < 0.01).
“In model J, HR for BGAL was greater in women (5.54; confidence interval, 1.45-21.20) than in men (2.12; confidence interval, 1.04-4.32; for the difference between genders, P < 0.01).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ ResultsIn men, the link between post-lunch blood glucose and cardiovascular events stayed significant when all blood glucose values were included together (model E) or when HbA1c was added (model H).
“The association of cardiovascular events with BGAL remained significant when all BG values were added together (model E) or when HbA1c was added (model H).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown data§ DiscussionMen in the study had a more frequent smoking habit, greater total/HDL cholesterol ratio and AER, and a more frequent history of previous cardiovascular events than women.
“whereas men presented a more frequent smoking habit, greater total/HDL cholesterol ratio and AER, and a more frequent history of previous cardiovascular events.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ DiscussionFasting blood glucose and HbA1c had low predictive value for cardiovascular events in the present analysis.
“In contrast, when we tried to determine the predictive role of each component of BG control, we observed a low predictive value of FBG and HbA1c, in agreement with other observations concerning the prediction of atherosclerosis in subjects at risk for type 2 diabetes mellitus (33).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] 33. Temelkova-Kurktschiev T, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M 2000 Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 23:1830-1834
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown data§ DiscussionWomen in the study were older, had longer diabetes duration, and had greater BMI, HbA1c, and fibrinogen values than men.
“women were older, had a longer diabetes duration, and had greater BMI, HbA1c and fibrinogen values”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ DiscussionThe hazard ratio for cardiovascular events conferred by post-lunch blood glucose was 5.54 in women versus 2.12 in men, and the difference was statistically significant.
“In particular, HR for cardiovascular events conferred by postlunch BG was 5.54 in women vs. 2.12 in men, the difference being statistically significant.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Premisecitation§ First Published Online December 13, 2005Studies mostly in general populations indicate that glucose measured after a challenge predicts cardiovascular events and death better than fasting glucose.
“predicts the incidence of cardiovascular events and mortality more than fasting BG”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [13] 13. Haffner S 1998 The importance of hyperglycemia in the non fasting state to the development of cardiovascular disease. Endocr Rev 19:583-592
Not checked in the free run.
- cites [14] 14. Bonora E, Muggeo M 2001 Postprandial blood glucose as a risk factor for cardiovascular disease in type 2 diabetes: the epidemiological evidence. Diabetologia 44:2107-2114
Not checked in the free run.
- cites [15] 15. Heine RJ, Dekker JM 2002 Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia 45:461-475
Not checked in the free run.
- cites [16] 16. Gerich JE 2003 Clinical significance, pathogenesis and management of postprandial hyperglycemia. Arch Intern Med 163:1306-1316
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Subjects and MethodsThe Reflolux II reflectance meter used in hospital and at home had previously documented reliability in the authors' laboratory.
“the reflectance meter used both in the hospital and at home was Reflolux II (Roche, Mannheim, Germany), whose reliability in our laboratory has been previously described (27).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] 27. Trovati M, Burzacca S, Mularoni E, Massucco P, Cavalot F, Mattiello L, Anfossi G 1991 Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. Diabetologia 34:662-667
Not checked in the free run.
May combine two claims.
Interpretationown data§ DiscussionThe paper's main conclusion is that blood glucose after lunch predicts cardiovascular events over a 5-year follow-up in type 2 diabetic patients more than fasting blood glucose, and that this effect is stronger in women than in men.
“The main messages of this paper are that BG after lunch predicts the occurrence of cardiovascular events in a 5-yr follow-up in type 2 diabetic patients more than fasting BG, and that this effect is stronger in women than in men.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes StudyType 2 diabetes patients have higher cardiovascular illness and death rates.
“P ATIENTS AFFECTED BY type 2 diabetes show an increased cardiovascular morbidity and mortality (1, 2).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] 1. Laakso M, Lehto S 1997 Epidemiology of macrovascular disease in diabetes. Diabetes Rev 5:294-315
Not checked in the free run.
- cites [2] 2. Stamler J, Vaccaro O, Necton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Risk Group 1993 Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIn a previous study of diet-treated type 2 diabetic patients, blood glucose values before lunch were significantly lower than blood glucose measured 2 hours after breakfast.
“In a study carried out on diet-treated type 2 diabetic patients, we showed that BG values before lunch were significantly lower than BG measured 2 h after breakfast (31).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] 31. Trovati M, Ponziani MC, Massucco P, Anfossi G, Mularoni EM, Burzacca S, - Tassone F, Perna P, Traversa M, Cavalot F 2002 Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. Eur J Clin Invest 32:179-186
Not checked in the free run.
May combine two claims.
Premisecitation§ First Published Online December 13, 2005In the Diabetes Intervention Study, post-breakfast glucose, unlike fasting glucose, predicted myocardial infarction and death in patients newly diagnosed with type 2 diabetes.
“BG after breakfast, but not fasting BG, has been found to predict myocardial infarction and mortality in newly diagnosed type 2 diabetic patients (11).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] 11. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J 1996 Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577-1583
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ First Published Online December 13, 2005Other studies find no significant sex differences in that risk.
“whereas other studies do not show significant gender-related differences (6).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] 6. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM, HeineRJ 1999 Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study. Diabetologia 42:926-931
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes StudyBlood glucose control has been linked to cardiovascular events in people with type 2 diabetes.
“A relationship between BG control and cardiovascular events has also been observed in type 2 diabetic patients (10-12).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [10] 10. Laakso M 1999 Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48:937-942
Not checked in the free run.
- cites [11] 11. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J 1996 Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577-1583
Not checked in the free run.
- cites [12] 12. Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hormann A, Holle R 1996 Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 39:1540-1545
Not checked in the free run.
May combine two claims.
Interpretationown data§ First Published Online December 13, 2005In type 2 diabetes, postprandial glucose, not fasting glucose, independently predicts cardiovascular events.
“Postprandial, but not fasting, blood glucose is an independent risk factor for cardiovascular events in type 2 diabetes”
Quote in the paperSubstantial claim- Rests on an assumption: The blood glucose profiles used at baseline reflect the patients' usual glycemic control.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIn the Diabetes Intervention Study, blood glucose after breakfast predicted cardiovascular events.
“BG after breakfast predicted cardiovascular events in the DIS, but not in our study”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] 11. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J 1996 Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577-1583
Not checked in the free run.
May combine two claims.
Premisecitation§ DiscussionIn type 2 diabetes, the preprandial blood glucose baseline on which postmeal excursions are superimposed is not stable as in nondiabetic subjects but falls from morning to evening, probably because the early morning rise in counterregulatory hormones wanes.
“As we described in a previous study, in type 2 diabetes the BG baseline on which postmeal excursions are superimposed (what we called the preprandial baseline) is not stable as it is in nondiabetic subjects, but decreases from morning to evening, probably because of waning of the early morning increase in counterregulatory hormones (31).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] 31. Trovati M, Ponziani MC, Massucco P, Anfossi G, Mularoni EM, Burzacca S, - Tassone F, Perna P, Traversa M, Cavalot F 2002 Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. Eur J Clin Invest 32:179-186
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ First Published Online December 13, 2005Postchallenge and postprandial glucose measurements should be treated as separate.
“postprandial and postload glucose concentrations should be kept clearly distinct (17).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] 17. Yudkin JS 2002 Post-load hyperglycaemia-an inappropriate therapeutic target. Lancet 359:166-167
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Statistical analysisThe proportional hazards assumption was tested with a log cumulative hazard plot.
“Assumption of proportionality of hazards was tested using the log cumulative hazard plot, that is, the plot of log ( -log [S(t)]) vs. log of survival time, where S(t) represents the survival function.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationcitation§ DiscussionBecause postprandial excursions are superimposed on a falling preprandial blood glucose baseline, glycemic profiles in the present patients appear rather flat.
“Thus, because postprandial excursions are superimposed to a falling preprandial BG baseline, glycemic profiles look rather flat in our patients (31).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] 31. Trovati M, Ponziani MC, Massucco P, Anfossi G, Mularoni EM, Burzacca S, - Tassone F, Perna P, Traversa M, Cavalot F 2002 Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. Eur J Clin Invest 32:179-186
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ First Published Online December 13, 2005In the general population, cardiovascular death rates are two to five times higher in men than women.
“In the general population, cardiovascular mortality rate is two to five times greater in men than in women (19, 20).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [19] 19. Jackson R, Chambless L, Higgins M, Kuulasmaa K, Wijnberg L, Williams D 1997 WHO Monica Project, and ARIC Study sex difference in ischaemic heart disease mortality and risk factors in 46 communities: an ecologic analysis. Cardiovasc Risk Factors 7:43-54
Not checked in the free run.
- cites [20] 20. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P 1999 Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14786 middle-aged men and women in Finland. Circulation 99:1165-1172
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Subjects and MethodsFollow-up was completed for 484 of 529 patients (91.4%) by 2000.
“in the year 2000, the follow-up was completed for 484 patients (91.4%).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Statistical analysisResidual analysis used log-cumulative hazard plots of Cox-Snell residuals to check linear prediction adequacy in the Cox models.
“Residual analysis was conducted using log-cumulative hazard plots of Cox-Snell residuals to ascertain the adequacy of linear prediction in the Cox models.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown data§ DiscussionOnly a minority of the present patients measured blood glucose before lunch, so lunch-induced blood glucose excursions could not be evaluated in the whole cohort.
“Thus, because only a minority of our patients measured BG before lunch, we could not evaluate the lunch-induced BG excursions in all of the cohort.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ DiscussionThe discrepancy between the Diabetes Intervention Study and the present study regarding post-breakfast blood glucose is not surprising because breakfast in Germany and northwestern Italy differs strikingly in caloric and carbohydrate content.
“this apparent discrepancy is not surprising because of the striking differences between the caloric and carbohydrate contents of breakfast in Germany and that in northwestern Italy.”
Quote in the paperNot a substantial claim- Rests on an assumption: In Piedmont, breakfast is frequently a virtual meal consisting only of a cup of coffee and sometimes a small piece of bread.
Classified as probably not a substantial claim.
Premisecitation§ First Published Online December 13, 2005Some meta-analyses report hyperglycemia as a stronger cardiovascular risk factor in women than men.
“Some meta-analyses state that hyperglycemia is a stronger cardiovascular risk factor in women than in men (22, 23)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [22] 22. Orchard TJ 1996 The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med 28:323-333
Not checked in the free run.
- cites [23] 23. Lee WL, Cheung AM, Cape D, Zinman B 2000 Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 23:962-968
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ First Published Online December 13, 2005Other meta-analyses report that sex differences vanish after adjustment for major cardiovascular risk factors.
“whereas other state that gender-related differences disappear after adjustment for the main cardiovascular risk factors (24).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] 24. Kanaya AM, Grady D, Barrett-Connor E 2002 Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 162:1737-1745
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionAcarbose reduced the risk of myocardial infarction in type 2 diabetic patients.
“Acarbose also reduced the risk of myocardial infarction in type 2 diabetic patients (35)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] 35. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M 2004 - Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25:10-16
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionAcarbose slowed the progression of intima media thickness of carotid arteries in subjects with impaired glucose tolerance.
“and slowed the progression of intima media thickness of carotid arteries in subjects with impaired glucose tolerance (36).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] 36. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, TemelkovaKurktschiev T 2004 Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 35: 1073-1078
Not checked in the free run.
The paper relies on this without support.
No prior study has examined whether sex affects the predictive value of postprandial glucose in patients with established type 2 diabetes.
“As far as we know, no study addressed the influence of gender in the predictive power of postprandial (not postchallenge) BG in patients with an established diagnosis of type 2 diabetes.”
The paper relies on this without support.
The blood glucose profiles used at baseline reflect the patients' usual glycemic control.
“To get BG values truly reflecting the real glycemic control, we considered BG profiles available for clinical purposes at the routine visit in which the cardiovascular risk factors and HbA1c were measured”
The paper relies on this without support.
Record linkage with hospital discharge and population registers accurately identifies cardiovascular events and deaths.
“An individual record linkage with the hospital discharge database of the Piedmont region ( ∼ 4,200,000 inhabitants), the region in northwest Italy that includes Turin (the capital, with about 1,000,000 inhabitants), was conducted”
“An individual record linkage using the individual fiscal code as the key linkage was conducted with the Turin historical population register”
The paper relies on this without support.
The clinic-based cohort is representative of patients with type 2 diabetes generally.
“In a population of 529 (284 men and 245 women) consecutive type 2 diabetic patients attending our diabetes clinic”
The paper relies on this without support.
In Piedmont, breakfast is frequently a virtual meal consisting only of a cup of coffee and sometimes a small piece of bread.
“Actually, breakfast in the Piedmont is frequently a virtual meal, consisting only of a cup of coffee with, sometimes, a small piece of bread.”
The paper relies on this without support.
Hypoglycemic drugs are usually given in the morning.
“because hypoglycemic drugs are usually given in the morning”
The paper relies on this without support.
The differences between blood glucose after lunch and after breakfast underestimate the after-lunch glycemic increases.
“(which underestimate the after lunch glycemic increases)”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Postprandial dysmetabolism independently predicts future cardiovascular events even in people without diabetes.
“Post-prandial dysmetabolism is an independent predictor of future cardiovascular events even in nondiabetic individuals.”
From Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health (2008) · cites this paper as [8]
The Discussion (page unavailable) reports that postprandial blood glucose independently predicts cardiovascular events, but the study measured this in patients with type 2 diabetes. The paper discusses cardiovascular risk in the general population, yet does not establish the claimed postprandial prediction in nondiabetic individuals. (LLM, conf=0.90)
Experimental — accuracy not yet measuredThere are continuous linear direct relationships between post-challenge glucose levels and the risks of cardiovascular death and all-cause mortality.
“Continuous linear direct relationships exist between glucose levels after a glucose challenge and the risks of both CV death and all-cause mortality (8).”
From Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health (2008) · cites this paper as [8]
The introduction (page unavailable) reports an association between higher blood glucose and cardiovascular disease, and the study reports that glucose after lunch predicted cardiovascular events. Our copy does not establish a continuous linear relationship between post-challenge glucose and either cardiovascular death or all-cause mortality; it also distinguishes post-challenge from postprandial glucose. (LLM, conf=0.78)
Experimental — accuracy not yet measuredThe adverse effect of post-prandial or post-challenge hyperglycaemia appears stronger than that of fasting hyperglycaemia.
“The adverse impact of post-prandial or post-challenge (OGTT) hyperglycaemia seems to be even stronger than that of fasting hyperglycaemia [5][6][7][8][9].”
From Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus (2006) · cites this paper as [7]
Cites
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063 · see citing works
Coutinho, M., Gerstein, H. C., Wang, Y., & Yusuf, S. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.233 · Cited by 1,685 · see citing works
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624 · see citing works
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371 · see citing works
Modelling Survival Data in Medical Research.
McLachlan, G. J., & Collett, D. (1994) · Biometrics · doi:10.2307/2533471 · Cited by 1,023 · see citing works
Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1165 · Cited by 890 · see citing works
Hanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873 · see citing works
Hyperglycemia and cardiovascular disease in type 2 diabetes.
Laakso, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.937 · Cited by 753 · see citing works
Hanefeld, M. (2004) · European Heart Journal · doi:10.1016/s0195-668x(03)00468-8 · Cited by 641 · see citing works
Barrett-Connor, E. L. (1991) · JAMA · doi:10.1001/jama.265.5.627 · Cited by 638 · see citing works
de Vegt, F., Dekker, J. M., Ruhé, H. G., Stehouwer, C. D. A., Nijpels, G., Bouter, L. M., & Heine, R. J. (1999) · Diabetologia · doi:10.1007/s001250051249 · Cited by 611 · see citing works
Temelkova-Kurktschiev, T. S., Koehler, C., Henkel, E., Leonhardt, W., Fuecker, K., & Markolf Hanefeld, E. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1830 · Cited by 543 · see citing works
Lee, W. L., Cheung, A. M., Cape, D., & Zinman, B. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.962 · Cited by 442 · cited 1× · see citing works
“Some meta-analyses state that hyperglycemia is a stronger cardiovascular risk factor in women than in men (22, 23), whereas other state that gender-related differences disappear after adjustment for the main cardiovascular risk factors (24).”
BackgroundEsposito, K., Giugliano, D., Nappo, F., & Marfella, R. (2004) · Circulation · doi:10.1161/01.cir.0000134501.57864.66 · Cited by 440 · see citing works
Bonora, E., & Muggeo, M. (2001) · Diabetologia · doi:10.1007/s001250100020 · Cited by 418 · see citing works
Postprandial Glucose Regulation and Diabetic Complications
Ceriello, A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2090 · Cited by 362 · cited 1× · see citing works
“Many biochemical pathways could be responsible for the influence exerted by postprandial BG on the occurrence of cardiovascular events (13, 16, 38, 39).”
BackgroundClinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
Gerich, J. E. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1306 · Cited by 321 · see citing works
PAN, W.-H., Blanco-Cedres, L., Liu, K., Dyer, A. R., Schoenberger, J. A., Shekelle, R. B., Stamler, R., SMITH, D., Collette, P., & Stamler, J. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114266 · Cited by 281 · see citing works
Markolf Hanefeld, E., Chiasson, J., Koehler, C., Henkel, E., Schäper, F., & Temelkova-Kurktschiev, T. S. (2004) · Stroke · doi:10.1161/01.str.0000125864.01546.f2 · Cited by 253 · see citing works
Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults
Saydah, S. H., Miret, M., Sung, J., Varas, C., Gause, D., & Brancati, F. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1397 · Cited by 221 · see citing works
The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease
Haffner, S. M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0343 · Cited by 193 · see citing works
Standl, E., Balletshofer, B. M., Dahl, B., Weichenhain, B., Stiegler, H., Hörmann, A., & Holle, R. (1996) · Diabetologia · doi:10.1007/s001250050612 · Cited by 192 · see citing works
The DECODE Study Group, & Hu, G. (2003) · Diabetologia · doi:10.1007/s00125-003-1096-6 · Cited by 184 · see citing works
The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications
Ceriello, A. (2003) · Diabetologia · doi:10.1007/s00125-002-0931-5 · Cited by 181 · see citing works
Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease
Heine, R. J., & Dekker, J. M. (2002) · Diabetologia · doi:10.1007/s00125-001-0726-0 · Cited by 146 · see citing works
Muggeo, M., Verlato, G., Bonora, E., Zoppini, G., Corbellini, M., & de Marco, R. (1997) · Circulation · doi:10.1161/01.cir.96.6.1750 · Cited by 142 · see citing works
What does postprandial hyperglycaemia mean?
Heine, R. J., Balkau, B., Ceriello, A., Prato, S. D., Horton, E. S., & Taskinen, M. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01149.x · Cited by 139 · see citing works
Is hyperglycemia associated with cardiovascular disease? The Framingham Study
Wilson, P. W. F., Cupples, L. A., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90729-2 · Cited by 128 · see citing works
Orchard, T. J. (1996) · Annals of Medicine · doi:10.3109/07853899608999089 · Cited by 95 · see citing works
Trovati, M., Burzacca, S., Mularoni, E., Massucco, P., Cavalot, F. L., Mattiello, L., & Anfossi, G. (1991) · Diabetologia · doi:10.1007/bf00400996 · Cited by 31 · see citing works
Self-citationJanghorbani, M., Jones, R. B., Gilmour, W. H., Hedley, A. J., & Zhianpour, M. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90161-9 · Cited by 23 · see citing works
Post-load hyperglycaemia—an inappropriate therapeutic target
Yudkin, J. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07346-4 · Cited by 16 · see citing works
Trovati, M., Ponziani, M. C., Massucco, P., Anfossi, G., Mularoni, E., Burzacca, S., Tassone, F., Perna, P., Traversa, M., & Cavalot, F. L. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00965.x · Cited by 12 · see citing works
Self-citationKanaya, A. M., Grady, D., & Barrett-Connor, E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1737 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [29]29. Cochran WG and Cox GM 1950 Experimental designs. New York: Wiley & Sons
Cited by
Sorted by citations
Breaking Up Prolonged Sitting Reduces Postprandial Glucose and Insulin Responses
Dunstan, D. W., Kingwell, B. A., Larsen, R., Healy, G. N., Cerin, E., Hamilton, M. T., Shaw, J. E., Bertovic, D. A., Zimmet, P. Z., Salmon, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1931 · Cited by 1,203 · see citing works
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Timon, I. M. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 982 · see citing works
Augustin, L. S. A., Kendall, C. W. C., Jenkins, D. J. A., Willett, W. C., Astrup, A., Barclay, A. W., Björck, I., Brand-Miller, J. C., Brighenti, F., Buyken, A. E., et al. (2015) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.05.005 · Cited by 707 · see citing works
Rodbard, H. W., Blonde, L., Ss, B., Brett, E. M., Cobin, R. H., Handelsman, Y., Hellman, R., Jellinger, P. S., Jovanovic, L. G., Levy, P., et al. (2007) · Endocrine Practice · doi:10.4158/ep.13.s1.1 · Cited by 693 · see citing works
O’Keefe, J. H., & Bell, D. S. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.107 · Cited by 538 · see citing works
Ito, F., Sono, Y., & Ito, T. (2019) · Antioxidants · doi:10.3390/antiox8030072 · Cited by 535 · see citing works
O’Keefe, J. H., Gheewala, N. M., & O’Keefe, J. O. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.016 · Cited by 497 · see citing works
Glycemic Variability: How Do We Measure It and Why Is It Important?
Suh, S., & Kim, J. H. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.273 · Cited by 439 · see citing works
The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes
Zinman, B., Hoogwerf, B. J., García, S. D., Milton, D. R., Giaconia, J. M., Kim, D. D. H., TRAUTMANN, M. E., & Brodows, R. G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-7-200704030-00003 · Cited by 422 · see citing works
Bailey, D. P., & Locke, C. D. (2014) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2014.03.008 · Cited by 358 · see citing works
Nalysnyk, L., Hernandez‐Medina, M., & Krishnarajah, G. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01160.x · Cited by 343 · see citing works
Cavalot, F., Pagliarino, A., Valle, M., Di Martino, L., Bonomo, K., Massucco, P., Anfossi, G., & Trovati, M. (2011) · Diabetes Care · doi:10.2337/dc10-2414 · Cited by 322 · see citing works
Self-citationDeFronzo, R. A., & Abdul‐Ghani, M. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.013 · Cited by 318 · see citing works
Monnier, L., Colette, C., & Owens, D. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200618 · Cited by 297 · see citing works
Glucose metabolism and hyperglycemia
Giugliano, D., Ceriello, A., & Esposito, K. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.217s · Cited by 278 · see citing works
Monnier, L., & Colette, C. (2008) · Diabetes Care · doi:10.2337/dc08-s241 · Cited by 267 · see citing works
Ceriello, A., & Colagiuri, S. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02565.x · Cited by 266 · see citing works
Kraakman, M. J., Lee, M. K. S., Al‐Sharea, A., Dragoljevic, D., Barrett, T. J., Montenont, E., Basu, D., Heywood, S. E., Kammoun, H. L., Flynn, M., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92450 · Cited by 221 · see citing works
Alternating Bouts of Sitting and Standing Attenuate Postprandial Glucose Responses
Thorp, A. A., Kingwell, B. A., Sethi, P., Hammond, L. J., Owen, N. G., & Dunstan, D. W. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000337 · Cited by 215 · see citing works
Guideline for management of postmeal glucose
Ceriello, A., Colagiuri, S., Gerich, J. E., & Tuomilehto, J. O. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.01.012 · Cited by 208 · see citing works
Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring
Edelman, S. V., Argento, N. B., Pettus, J., & Hirsch, I. B. (2018) · Diabetes Care · doi:10.2337/dc18-1150 · Cited by 203 · see citing works
Giacchetti, G., Ronconi, V., Turchi, F., Agostinelli, L., Mantero, F., Rilli, S., & Boscaro, M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280108e6f · Cited by 196 · see citing works
Pharmacotherapy of type 2 diabetes: An update
Upadhyay, J., Pοlyzos, S. A., Perakakis, N., Thakkar, B., Paschou, S. Α., Katsiki, N., UNDERWOOD, P. C., Park, K., Seufert, J., Kang, E. S., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.010 · Cited by 190 · see citing works
Little, J. P., Jung, M. E., Wright, A. E., Wright, W., & Manders, R. J. F. (2014) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2013-0512 · Cited by 187 · see citing works
Postprandial Hyperglycemia and Glycemic Variability
Standl, E., Schnell, O., & Ceriello, A. (2011) · Diabetes Care · doi:10.2337/dc11-s206 · Cited by 183 · see citing works
Matsushita, K., Blecker, S., Pazin-Filho, A., Bertoni, A., Chang, P. P., Coresh, J., & Selvin, E. (2010) · Diabetes · doi:10.2337/db10-0165 · Cited by 183 · see citing works
Postprandial hyperglycemia as an etiological factor in vascular failure
Node, K., & Inoue, T. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-23 · Cited by 182 · see citing works
Guideline for management of postmeal glucose in diabetes
1 (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.002 · Cited by 182 · see citing works
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
CEFALO, C. M. A., Cinti, F., Moffa, S., Impronta, F., Sorice, G. P., Mezza, T., Pontecorvi, A., & Giaccari, A. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0828-y · Cited by 180 · see citing works
Di Flaviani, A., Picconi, F., Di Stefano, P., Giordani, I., Malandrucco, I., Maggio, P., Palazzo, P., Sgreccia, F., Peraldo, C., Farina, F., et al. (2011) · Diabetes Care · doi:10.2337/dc11-0034 · Cited by 179 · see citing works
Insulin therapy and hypoglycemia
McCall, A. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.03.001 · Cited by 177 · see citing works
Glucose variability: An emerging target for the treatment of diabetes mellitus
Frontoni, S., Bartolo, P. D., Avogaro, A., Bosi, E., Paolisso, G., & Ceriello, A. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.007 · Cited by 173 · see citing works
Jakubowicz, D. J., Wainstein, J., Åhrén, B., Landau, Z., Bar‐Dayan, Y., & Froy, O. (2015) · Diabetes Care · doi:10.2337/dc15-0761 · Cited by 172 · see citing works
Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract
Deguchi, Y., & Miyazaki, K. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-9 · Cited by 170 · see citing works
Post-Meal Glucose Peaks at Home Associate with Carotid Intima-Media Thickness in Type 2 Diabetes
Esposito, K., Ciotola, M., Carleo, D., Schisano, B., Sardelli, L., Tommaso, D. D., Misso, L., Saccomanno, F., Ceriello, A., & Giugliano, D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2000 · Cited by 162 · see citing works
van Dijk, J., Venema, M., van Mechelen, W., Stehouwer, C. D. A., Hartgens, F., & van Loon, L. J. C. (2013) · Diabetes Care · doi:10.2337/dc12-2620 · Cited by 154 · see citing works
Penno, G., Solini, A., Bonora, E., Fondelli, C., Orsi, E., Zerbini, G., Trevisan, R., Vedovato, M., Gruden, G., Laviola, L., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12073 · Cited by 151 · see citing works
Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update
Ceriello, A., Davidson, J., Markolf Hanefeld, E., Leiter, L. A., Monnier, L., Owens, D. R., Tajima, N., & Tuomilehto, J. O. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.05.006 · Cited by 149 · see citing works
Lowering Physical Activity Impairs Glycemic Control in Healthy Volunteers
Mikus, C. R., Oberlin, D. J., Libla, J. L., Taylor, A. M., Booth, F. W., & Thyfault, J. P. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31822ac0c0 · Cited by 147 · see citing works
Bioactive Properties of Marine Phenolics
Mateos, R., Pérez‐Correa, J. R., & Domı́nguez, H. (2020) · Marine Drugs · doi:10.3390/md18100501 · Cited by 146 · see citing works
Role of melatonin in metabolic regulation
Korkmaz, A., Topal, T., Tan, D., & Reiter, R. J. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9117-5 · Cited by 145 · see citing works
Natural History of Cardiovascular Disease in Patients With Diabetes
Miličević, Z., Raz, I., Beattie, S. D., Campaigne, B. N., Sarwat, S., Gromniak, E., Kowalska, I., Galić, E., Tan, M. H., & Hanefeld, M. (2008) · Diabetes Care · doi:10.2337/dc08-s240 · Cited by 142 · see citing works
Bonora, E., Corrao, G., Bagnardi, V., Ceriello, A., Comaschi, M., Montanari, P., & Meigs, J. B. (2006) · Diabetologia · doi:10.1007/s00125-006-0203-x · Cited by 141 · see citing works
Teong, X. T., Liu, K., Vincent, A. D., Bensalem, J., Liu, B., Hattersley, K. J., Zhao, L., Feinle‐Bisset, C., Sargeant, T. J., Wittert, G., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02287-7 · Cited by 141 · see citing works
Alpha-glucosidase inhibitors 2012 – cardiovascular considerations and trial evaluation
Standl, E., & Schnell, O. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112441524 · Cited by 140 · see citing works
Glucagon‐like peptide‐1‐based therapies and cardiovascular disease: looking beyond glycaemic control
Anagnostis, P. G., Athyros, V. G., Adamidou, F., Panagiotou, A., Kita, M. D., Karagiannis, A. I., & Mikhailidis, D. P. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01345.x · Cited by 140 · see citing works
Guardado‐Mendoza, R., Prioletta, A., Jiménez-Ceja, L. M., Sosale, A., & Folli, F. B. (2013) · Archives of Medical Science · doi:10.5114/aoms.2013.34991 · Cited by 139 · see citing works
Metabolic diseases and associated complications: sex and gender matter
Kautzky‐Willer, A., & Handisurya, A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02161.x · Cited by 138 · see citing works
Schulze, C., Bangert, A., Kottra, G., Geillinger, K. E., Schwanck, B., Vollert, H., Blaschek, W., & Daniel, H. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400016 · Cited by 137 · see citing works
Doran, B., Guo, Y., Xu, J., WEINTRAUB, H. S., Mora, S., Maron, D. J., & Bangalore, S. (2014) · Circulation · doi:10.1161/circulationaha.114.010001 · Cited by 135 · see citing works
Optimal prandial timing of bolus insulin in diabetes management: a review
Slattery, D., Amiel, S. A., & Choudhary, P. (2018) · Diabetic Medicine · doi:10.1111/dme.13525 · Cited by 132 · see citing works
You, Y., Li, W., Liu, J., Li, X., Fu, Y., & Ma, X. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.697633 · Cited by 132 · see citing works
Miao, L., Xu, Y. B., Jia, C., Zhang, B., Niu, M., & Zhao, S. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117841 · Cited by 129 · see citing works
Exercise therapy in Type 2 diabetes
Praet, S., & van Loon, L. J. C. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0129-0 · Cited by 128 · see citing works
Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses
Lasserson, D. S., Glasziou, P., Perera, R., Holman, R. R., & Farmer, A. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1468-7 · Cited by 124 · see citing works
Platelets and diabetes mellitus
Santilli, F., Simeone, P., Liani, R., & Davı̀, G. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.05.002 · Cited by 123 · see citing works
Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects
Carnevale, R., Silvestri, R., Loffredo, L., Novo, M., Cammisotto, V., Castellani, V., Bartimoccia, S., Nocella, C., & Violi, F. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13589 · Cited by 121 · see citing works
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease
Goodarzi, M. O., & Rotter, J. I. (2020) · Circulation Research · doi:10.1161/circresaha.119.316065 · Cited by 117 · see citing works
Kohnert, K., Augstein, P., Zander, E., Heinke, P., Peterson, K., Freyse, E., Hovorka, R., & Salzsieder, E. (2009) · Diabetes Care · doi:10.2337/dc08-1956 · Cited by 110 · see citing works
Nishimura, R., Tanaka, Y., Koiwai, K., Inoue, K., Hach, T., Salsali, A., Lund, S. S., & Broedl, U. C. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0169-9 · Cited by 109 · see citing works
Exenatide: a review from pharmacology to clinical practice
Gentilella, R., Bianchi, C., Rossi, A., & Rotella, C. M. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01018.x · Cited by 108 · see citing works
Mechanick, J. I., Garber, A. J., Grunberger, G., Handelsman, Y., & Garvey, W. T. (2018) · Endocrine Practice · doi:10.4158/ps-2018-0139 · Cited by 107 · see citing works
Manco, M., Panunzi, S., Macfarlane, D. P., Golay, A., Melander, O., Konrad, T., Petrie, J. R., & Mingrone, G. (2010) · Diabetes Care · doi:10.2337/dc09-2261 · Cited by 105 · see citing works
Exercising for Metabolic Control: Is Timing Important?
Haxhi, J., di Palumbo, A. S., & Sacchetti, M. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000343788 · Cited by 104 · see citing works
Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein
Watanabe, H., Inaba, Y., Kimura, K., Matsumoto, M., Kaneko, S., Kasuga, M., & Inoue, H. (2017) · Nature Communications · doi:10.1038/s41467-017-02537-6 · Cited by 104 · see citing works
Glucose tolerance is negatively associated with circulating progenitor cell levels
Fadini, G. P., Pucci, L., Vanacore, R., Baesso, I., Penno, G., Balbarini, A., Stefano, R. D., Miccoli, R., de Kreutzenberg, S., Coracina, A., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0732-y · Cited by 104 · see citing works
Pulsford, R. M., Blackwell, J. R., Hillsdon, M. M., & Kos, K. (2016) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2016.08.012 · Cited by 103 · see citing works
Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
Gerich (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s8216 · Cited by 101 · see citing works
Pramlintide and the treatment of diabetes: a review of the data since its introduction
Younk, L. M., Mikeladze, M., & Davis, S. N. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.581663 · Cited by 99 · see citing works
Rynders, C. A., Weltman, J. Y., Jiang, B., Breton, M. D., Patrie, J. T., Barrett, E. J., & WELTMAN, A. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2687 · Cited by 98 · see citing works
Sala, L. L., Mrakic‐Sposta, S., Micheloni, S., Prattichizzo, F., & Ceriello, A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0748-2 · Cited by 98 · see citing works
Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes
Shukla, A. P., Andono, J., Touhamy, S. H., Casper, A., Iliescu, R. G., Mauer, E., Shan Zhu, Y., Ludwig, D. S., & Aronne, L. J. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000440 · Cited by 96 · see citing works
Value of Self-Monitoring Blood Glucose Pattern Analysis in Improving Diabetes Outcomes
Parkin, C. G., & Davidson, J. A. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300314 · Cited by 96 · see citing works
Franzini, L., Ardigò, D., Cavalot, F. L., Miccoli, R., Rivellese, A. A., Trovati, M., Zavaroni, I., & Vaccaro, O. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.12.003 · Cited by 96 · see citing works
Self-citationModification of Insulin Sensitivity and Glycemic Control by Activity and Exercise
ROBERTS, C. K., LITTLE, J. P., & THYFAULT, J. P. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318295cdbb · Cited by 95 · see citing works
Cavalot, F. L. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12140 · Cited by 93 · see citing works
Self-citationPhlorotannins from Alaskan Seaweed Inhibit Carbolytic Enzyme Activity
Kellogg, J. J., Grace, M. H., & Lila, M. A. (2014) · Marine Drugs · doi:10.3390/md12105277 · Cited by 93 · see citing works
Road Maps to Achieve Glycemic Control in Type 2 Diabetes Mellitus
Jellinger, P. S., Davidson, J. A., Blonde, L., EINHORN, D. F., Grunberger, G., Handelsman, Y., Hellman, R., Lebovitz, H. E., Levy, P., & Roberts, V. L. (2007) · Endocrine Practice · doi:10.4158/ep.13.3.260 · Cited by 92 · see citing works
Ahn, C. H., Min, S. H., Lee, D.-H., Oh, T. J., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., Ha, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00191 · Cited by 91 · see citing works
Thomsen, M. N., Skytte, M. J., Samkani, A., Carl, M. H., Weber, P., Astrup, A., Chabanova, E., Fenger, M., Frystyk, J., Hartmann, B., et al. (2022) · Diabetologia · doi:10.1007/s00125-021-05628-8 · Cited by 90 · see citing works
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus
Santilli, F., Formoso, G., Sbraccia, P., Averna, M. R., Miccoli, R., Fulvio, P. D., Ganci, A., Pulizzi, N., Lattanzio, S., Ciabattoni, G., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03742.x · Cited by 90 · see citing works
Monnier, L., Colette, C., & Owens, D. R. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.962 · Cited by 89 · see citing works
Kautzky‐Willer, A., Brazzale, A. R., Moro, E., Vrbíková, J., Bendlová, B., Sbrignadello, S., Tura, A., & Pacini, G. (2012) · Obesity · doi:10.1038/oby.2011.384 · Cited by 88 · see citing works
Postprandial and Basal Glucose in Type 2 Diabetes: Assessment and Respective Impacts
Monnier, L., Colette, C., & Owens, D. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0239 · Cited by 88 · see citing works
Mikus, C. R., Oberlin, D. J., Libla, J. L., Boyle, L. J., & Thyfault, J. P. (2012) · Diabetologia · doi:10.1007/s00125-012-2490-8 · Cited by 85 · see citing works
Picconi, F., Parravano, M., Ylli, D., Pasqualetti, P., Coluzzi, S., Giordani, I., Malandrucco, I., Lauro, D., Scarinci, F., Giorno, P., et al. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0971-4 · Cited by 84 · see citing works
Glycemic variability and diabetes retinopathy: A missing link
Hsu, C.-R., Chen, Y., & Sheu, W. H. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.013 · Cited by 83 · see citing works
Monnier, L., & Colette, C. (2009) · Diabetes Care · doi:10.2337/dc09-s310 · Cited by 82 · see citing works
Maessen, D. E., Hanssen, N. M. J., Scheijen, J. L. J. M., Kallen, C., van Greevenbroek, M. M. J., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Diabetes Care · doi:10.2337/dc14-2605 · Cited by 82 · see citing works
Colette, C., & Monnier, L. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-985157 · Cited by 81 · see citing works
Pearce, K. L., Noakes, M., Keogh, J., & Clifton, P. M. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.638 · Cited by 80 · see citing works
Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
Selvin, E., Rawlings, A. M., Lutsey, P. L., Maruthur, N. M., Pankow, J. S., Steffes, M. W., & Coresh, J. (2015) · Diabetes · doi:10.2337/db15-0607 · Cited by 80 · see citing works
Madsbad, S. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.019 · Cited by 78 · see citing works
Mariappan, M. M., Féliers, D., Mummidi, S., Choudhury, G. G., & Kasinath, B. S. (2007) · Diabetes · doi:10.2337/db05-1334 · Cited by 78 · see citing works
The second-meal phenomenon is associated with enhanced muscle glycogen storage in humans
Jovanović, A., Leverton, E., Solanky, B., Ravikumar, B., Snaar, J. E. M., Morris, P. G., & Taylor, R. (2009) · Clinical Science · doi:10.1042/cs20080542 · Cited by 76 · see citing works
Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings
Ceriello, A. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.038 · Cited by 76 · see citing works
Lin, H., Lee, B., Ho, Y., Lin, Y., Chen, C., Hsu, H., Lin, M., Chien, K., & Chen, M.-F. (2009) · Diabetes Care · doi:10.2337/dc08-2337 · Cited by 75 · see citing works
Exercise Therapy in Type 2 Diabetes
van Dijk, J., Tummers, K., Stehouwer, C. D. A., Hartgens, F., & van Loon, L. J. C. (2012) · Diabetes Care · doi:10.2337/dc11-2112 · Cited by 75 · see citing works
Atherogenicity of postprandial hyperglycemia and lipotoxicity
Ceriello, A., & Genovese, S. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9341-8 · Cited by 74 · see citing works
King, D. G., Walker, M., Campbell, M. D., Breen, L., Stevenson, E., & West, D. J. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy019 · Cited by 74 · see citing works
- Authors
- Cavalot, F., Petrelli, A., Traversa, M., Bonomo, K., Fiora, E., Conti, M., Anfossi, G., Costa, G., & Trovati, M.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- University of Turin (IT)
- Corresponding author
- Trovati, M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-03
- Volume
- 91
- Issue
- 3
- Pages
- 813-819
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1967633321
- Cited by
- 569
- References
- 34
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 16 · 2023: 26 · 2022: 22 · 2021: 22 · 2020: 34 · 2019: 27 · 2018: 31 · 2017: 33 · 2016: 37 · 2015: 35 · 2014: 37 · 2013: 27 · 2012: 40
- FWCI
- 21.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- postprandial blood glucose, fasting blood glucose, type 2 diabetes, cardiovascular events, cardiovascular risk prediction, sex differences, postprandial hyperglycemia, HbA1c
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Fasting, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Sex Characteristics, Biomarkers, Body Mass Index, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-27.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-27.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review